content

National Database of Drug Formulations In India A Priority

In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database on every medicinal composition...

An Encrypt Medicine Suppresses COVID-19 And Its Variants

Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is developed so that natural...

$5Bn Pharmaceutical Cooperation For Bispecific Antibodies

Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use in research and development...

Curing Cholestatic Liver Disease After Cognitive Impairment

Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems. There is presently no known...

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations

PHASTAR, aย global specialist biometrics contract research organization (CRO), has joined Lean Life Scienceโ€™s Oncology Development Programme (ODP2). The targeted programme aims to identify and...

3D COF Shows Good Hydrogen, CO2, And Methane Adsorption

In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c...

Top Biopharma Companies Show A Dip In Market Cap For Q3

The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read